Anzeige
Mehr »
Login
Mittwoch, 08.01.2025 Börsentäglich über 12.000 News von 683 internationalen Medien
Warum der Warren Buffett des Bergbaus alles auf diese Aktie setzt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
748 Leser
Artikel bewerten:
(2)

Joint Commission International announces publication of 7th Edition of International Accreditation Standards for Hospitals

Finanznachrichten News

Standards publish 1 April 2020 and become effective 1 October 2020

OAK BROOK, Illinois, Jan. 29, 2020 /PRNewswire/ -- In an effort to focus on continuous patient safety and quality improvements, as well as address dynamic changes in today's global health care environment, Joint Commission International (JCI) announces the publication of The Joint Commission International Accreditation Standards for Hospitals, 7th Edition on 1 April 2020.

Joint Commission International Logo

Beginning 1 October 2020, all hospitals and academic medical centers seeking accreditation or reaccreditation from JCI will need to comply with the updated set of accreditation standards, as they will be surveyed under the 7th edition.

JCI international standards are the basis for the accreditation of hospitals and academic medical centers throughout the world. The standards define the performance expectations, structures and functions that must be in place to be accredited by JCI.

The 7th edition will include two main sections on patient-centered care and health care organization management. Specific enhancements include new or revised standards in these areas:

  • International Patient Safety Goals
  • Care of Patients Chapter that addresses the management of clinical alarm systems, patients at risk of suicide or self-harm and lasers.
  • Prevention and Control of Infections Chapter that covers environmental cleanliness for laundry, linens and scrubs, as well as the protection of patients and staff from bloodborne pathogens.
  • Facility Management and Safety Chapter that includes fire safety, including the use of interim measures, clarification of expectations for availability of critical utilities and hemodialysis water quality.
  • Management of Information Chapter that reviews data access controls, protecting data and information, education and ongoing training of staff who use electronic medical records and the use of scribes.

Other enhancements include the clarification of sentinel events, adverse events and near misses, an expanded and unified glossary, and updated references and revised chapter overviews.

"We are pleased to introduce the 7th edition of our international accreditation standards for hospitals. These standards reflect the most up-to-date scientific evidence on patient safety as well as input from our current JCI accredited organizations and other expert stakeholders," says Paula Wilson, president and CEO, JCI. "This newest edition of the JCI hospital standards continues our 20-year history of helping accredited organizations improve the quality and safety of care they provide to patients around the globe. JCI is proud to be a partner with these outstanding organizations."

The Joint Commission International Accreditation Standards for Hospitals, 7th Edition will be available for purchase in English beginning 1 April 2020, followed by release in Chinese, Portuguese, Italian, Hebrew, Japanese, Indonesian, French and Spanish at a later date. The manual is complimentary for JCI accredited organizations.

For more information on JCI standards, please visit https://www.jointcommissioninternational.org/standards/.

About Joint Commission International
Joint Commission International (JCI) was established in 1994 as a division of Joint Commission Resources, Inc. (JCR), a wholly controlled, nonprofit affiliate of The Joint Commission. Through international accreditation and certification, advisory services, publications and education programs, JCI extends The Joint Commission's mission worldwide by helping improve the quality of patient care. JCI works with international health care organizations, public health agencies, health ministries and others in more than 100 countries. Visit www.jointcommissioninternational.org for more information.

Media Contact:
Maureen Lyons
Corporate Communications
(630) 792-5171
mlyons@jointcommission.org

Logo - https://mma.prnewswire.com/media/118169/joint_commission_international_logo.jpg

© 2020 PR Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.